# Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects

> **NCT00857870** · PHASE4 · COMPLETED · sponsor: **GWT-TUD GmbH** · enrollment: 96 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Metformin
- **DRUG:** Insulin glargine

## Key facts

- **NCT ID:** NCT00857870
- **Lead sponsor:** GWT-TUD GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-08
- **Final completion:** 2011-12
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2012-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00857870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00857870, "Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00857870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*